| Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes A Sveen, S Kilpinen, A Ruusulehto, RA Lothe, RI Skotheim Oncogene 35 (19), 2413-2427, 2016 | 506 | 2016 |
| Multi-omics of 34 colorectal cancer cell lines-a resource for biomedical studies KCG Berg, PW Eide, IA Eilertsen, B Johannessen, J Bruun, SA Danielsen, ... Molecular cancer 16, 1-16, 2017 | 374 | 2017 |
| Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ... The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016 | 321 | 2016 |
| Biomarker-guided therapy for colorectal cancer: strength in complexity A Sveen, S Kopetz, RA Lothe Nature Reviews Clinical Oncology 17 (1), 11-32, 2020 | 301 | 2020 |
| CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models PW Eide, J Bruun, RA Lothe, A Sveen Scientific reports 7 (1), 16618, 2017 | 294 | 2017 |
| ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis TH Ågesen, A Sveen, MA Merok, GE Lind, A Nesbakken, RI Skotheim, ... Gut 61 (11), 1560-1567, 2012 | 268 | 2012 |
| Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies A Sveen, J Bruun, PW Eide, IA Eilertsen, L Ramirez, A Murumägi, ... Clinical Cancer Research 24 (4), 794-806, 2018 | 251 | 2018 |
| Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ... Annals of Oncology 28 (5), 1023-1031, 2017 | 248 | 2017 |
| Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III … R Dienstmann, G Villacampa, A Sveen, MJ Mason, D Niedzwiecki, ... Annals of oncology 30 (10), 1622-1629, 2019 | 192 | 2019 |
| ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients A Sveen, TH Ågesen, A Nesbakken, GI Meling, TO Rognum, K Liestøl, ... Clinical cancer research 18 (21), 6001-6010, 2012 | 136 | 2012 |
| Genome-wide analysis of signal peptide functionality in Lactobacillus plantarum WCFS1 G Mathiesen, A Sveen, MB Brurberg, L Fredriksen, L Axelsson, ... BMC genomics 10, 1-13, 2009 | 124 | 2009 |
| Heterologous protein secretion by Lactobacillus plantarum using homologous signal peptides G Mathiesen, A Sveen, JC Piard, L Axelsson, VGH Eijsink Journal of applied microbiology 105 (1), 215-226, 2008 | 110 | 2008 |
| Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements P Paulo, FR Ribeiro, J Santos, D Mesquita, M Almeida, JD Barros-Silva, ... Neoplasia 14 (7), 600-IN15, 2012 | 109 | 2012 |
| Combination therapies with HSP90 inhibitors against colorectal cancer K Kryeziu, J Bruun, TK Guren, A Sveen, RA Lothe Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (2), 240-247, 2019 | 108 | 2019 |
| Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival A Sveen, TH Ågesen, A Nesbakken, TO Rognum, RA Lothe, RI Skotheim Genome medicine 3, 1-13, 2011 | 106 | 2011 |
| Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1 A Sveen, B Johannessen, T Tengs, SA Danielsen, IA Eilertsen, GE Lind, ... Genome Medicine 9, 1-16, 2017 | 96 | 2017 |
| CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer J Smeby, A Sveen, MA Merok, SA Danielsen, IA Eilertsen, MG Guren, ... Annals of Oncology 29 (5), 1227-1234, 2018 | 85 | 2018 |
| Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity J Bruun, K Kryeziu, PW Eide, SH Moosavi, IA Eilertsen, J Langerud, ... Clinical Cancer Research 26 (15), 4107-4119, 2020 | 81 | 2020 |
| Intra-patient inter-metastatic genetic heterogeneity in colorectal cancer as a key determinant of survival after curative liver resection A Sveen, IM Løes, S Alagaratnam, G Nilsen, M Høland, OC Lingjærde, ... PLoS genetics 12 (7), e1006225, 2016 | 75 | 2016 |
| Phospholipase C isozymes are deregulated in colorectal cancer–insights gained from gene set enrichment analysis of the transcriptome SA Danielsen, L Cekaite, TH Ågesen, A Sveen, A Nesbakken, ... PloS one 6 (9), e24419, 2011 | 71 | 2011 |
